Finerenone
RAiSiN
Approved small_molecule active
Quick answer
Finerenone for Patients With Type 2 Diabetes is a Approved program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chinese University of Hong Kong
- Indication
- Patients With Type 2 Diabetes
- Phase
- Approved
- Modality
- small_molecule
- Status
- active